INDV
NASDAQ · Pharmaceuticals
Indivior Pharmaceuticals Inc
$35.53
+0.65 (+1.86%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+52.69%
YTD
-0.56%
Open$35.00
Previous Close$34.88
Day High$35.63
Day Low$34.77
52W High$42.81
52W Low$22.22
Volume—
Avg Volume1.93M
Market Cap4.21B
P/E Ratio11.87
EPS$2.78
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$34.90
Above
SMA 200
$24.61
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+36.5% upside
Current
$35.53
$35.53
Target
$48.50
$48.50
$40.68
$48.50 avg
$71.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.17B | 1.05B | 1.33B |
| Net Income | 198.14M | 160.37M | 235.99M |
| Profit Margin | 17.0% | 16.1% | 17.8% |
| EBITDA | 247.21M | 211.20M | 342.24M |
| Free Cash Flow | — | — | 277.67M |
| Rev Growth | +11.2% | +11.2% | +22.2% |
| Debt/Equity | 5.43 | 5.43 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |